Navigation Links
Bone marrow cells used in bladder regeneration
Date:2/18/2013

A new approach to bladder regeneration is capitalizing on the potential of two distinct cell populations harvested from a patient's healthy bone marrow, a new study reports.

The Northwestern Medicine research, which will be published February 18 in the Proceedings of the National Academy of Sciences by lead author Arun K. Sharma, research assistant professor in urology at Northwestern University Feinberg School of Medicine and colleagues, is an alternative to contemporary tissue-engineering strategies. The bone marrow cells are being used to recreate the organ's smooth muscle, vasculature, and nerve tissue.

"We are manipulating a person's own disease-free cells for bladder tissue reformation," said Sharma, a member of the Institute for BioNanotechnology in Medicine and the Ann & Robert H. Lurie Children's Hospital of Chicago Research Center. "We have used the spina bifida patient population as a proof of concept model because those patients typically have bladder dysfunction. However, this regeneration approach could be used for people suffering from a variety of bladder issues where the bone marrow microenvironment is deemed normal."

In end-stage neurogenic bladder disease an illness often associated with spinal cord diseases like spina bifida the nerves which carry messages between the bladder and the brain do not work properly, causing an inability to pass urine. The most common surgical option, augmentation cystoplasty, involves placing a "patch" derived from an individual's bowel over a part of the diseased organ in order to increase its size. The current "gold standard," the procedure remains problematic because the bowel tissue introduces long-term complications like the development of electrolyte imbalance and bladder cancer.

Because Sharma's procedure does not use bowel tissue, it offers the benefits of augmentation without the association of long-term risks. His technique combines stem and progenitor cell
'/>"/>

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Bone marrow stem cells do not improve short-term recovery after heart attack
2. Study results: Adult stem cells from bone marrow
3. Autologous bone marrow-derived mononuclear cell transplants can reduce diabetic amputations
4. Cell therapy using patients own bone marrow may present option for heart disease
5. Bone marrow transplant arrests symptoms in model of Rett syndrome
6. Why cells stick: Phenomenon extends longevity of bonds between cells
7. Long noncoding RNAs control development of fat cells
8. Research improving breast cancer treatment by targeting tumor initiating cells
9. Artificial atoms allow for magnetic resonance on individual cells
10. Tumor blood vessels prevent the spread of cancer cells
11. Peering into living cells -- without dye nor fluophore
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a leader in ... biometric technology to industry leaders such as Intel, Jabra, ... validated, biometric wearable products. These products will be showcased ... Las Vegas . "Our ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally transforming the ... at international borders. Over the past decade, ePassports, biometric ... to self process through border control via eGates and ... of airports, seaports, and land borders across the globe. ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... 2015-2019"  report to their offering. One ... technology. With continuous advances in technology, it is important ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... brains are under intensive development all over the ... areas, according to a study just placed online. ... of Southern California chaired the eight-member committee which ... in Brain-Computer Interfaces," published in October by the ...
... Conn. A before-and-after study led by Yale biologists, ... genetic diversity of marine iguanas on the Galpagos Islands, ... the need to determine which environmental and biological factors ... to the authors, recurring El Nio events provide an ...
... Ossur, an emerging leader in the non-invasive orthopaedics ... is pleased to announce that the Journal of Trauma ... cervical collar study performed by the Mayo Clinic. The ... from Four Cervical Collars, finds that Ossurs products ...
Cached Biology News:Brain-computer link systems on the brink of breakthrough, study finds 2Global climate change: The impact of El Nio on Galpagos marine iguanas 2Mayo Clinic study: Ossur's collars superior in immobilization and reduction of pressure 2
(Date:1/23/2015)... Rockville, MD (PRWEB) January 23, 2015 ... delivers modern digital workplaces on Microsoft Office 365 and ... 2015 Future 50 Award program for being one of the ... of revenue and employee growth. , “To be recognized ...
(Date:1/22/2015)... GEA Niro Soavi the leader in high pressure ... 2000, which is ideal for new applications for processing ... . This compact laboratory homogenizer is the perfect solution ... additives and ingredients as well as for the ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Protocol Networks ... The growing team of brand-neutral, independent consultants, Protocol Networks ... Rogers explained that over the years, his company has ... Moroso, Town of Plainfield, as well as others. With ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently ... Supplements Pre-Conference seminar on probiotics in San Diego, CA. ... education conference for health care professionals. This year’s pre-conference seminar ... probiotics in health. Dr. Leyer spoke about the emerging topics ...
Breaking Biology Technology:Washington SmartCEO Announces Portal Solutions as 2015 Future 50 Award Winner Second Year in a Row 2Washington SmartCEO Announces Portal Solutions as 2015 Future 50 Award Winner Second Year in a Row 3GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2
... CAMBRIDGE, Mass., May 21 Biopure Corporation,(Nasdaq: BPUR ... fiscal,quarter ended April 30, 2008. For the quarter, the ... per common share, compared with a net loss,of $6.2 ... period in,2007. Class A common shares outstanding on April ...
... Genetics,Inc. (Amex: ILI ), today expressed praise ... Nondiscrimination Act (GINA). The bill was approved,unanimously in ... into law by,President George W. Bush today., ... are protected,from genetic discrimination from employers and insurance ...
... The New Best Practice Statements Were Presented at ... YOKNEAM, Israel and PLYMOUTH MEETING, Pennsylvania, May ... cryotherapy, announced today that the,American Urological Association has ... cryotherapy. The guidelines state,that cryoablation is a treatment ...
Cached Biology Technology:Biopure Announces 2008 Second Quarter Financial Results 2Biopure Announces 2008 Second Quarter Financial Results 3Biopure Announces 2008 Second Quarter Financial Results 4Biopure Announces 2008 Second Quarter Financial Results 5Biopure Announces 2008 Second Quarter Financial Results 6Biopure Announces 2008 Second Quarter Financial Results 7Biopure Announces 2008 Second Quarter Financial Results 8Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA) 2Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA) 3American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients 2American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients 3
... Clone/PAD: ZMD.414. Immunogen: Synthetic peptide ... mouse and rat mTOR (Mammalian target of ... for the human mTOR protein. On ... at ~235 kDa. Reactivity: Human (positive ...
...
From micro to giga sizes, from single prep to high-throughput, Invitrogen's range of plasmid purification kits offers superior performance to match the demands of your downstream application....
Request Info...
Biology Products: